Publications 2022 
　Original Paper
　
 
Gene expression changes related to bone mineralization, blood pressure and lipid metabolism in mouse kidneys after space travel 
Suzuki N, Iwamura Y, Nakai T, Kato K, Otsuki A, Uruno A, Saigusa D, Taguchi K, Suzuki M, Shimizu R, Yumoto A, Okada R, Shirakawa M, Shiba D, Takahashi S, Suzuki T, Yamamoto M.
Kidney Int   101, 92-105  (2022)
 
Cyclobutane Pyrimidine Dimers Produced with Narrowband UVB Are on Average More Mutagenic than Those with Broadband UVB in Mouse Skin 
Ikehata H, Yamamoto M.
Photochem Photobiol   98, 916-924  (2022)
池畑広伸講師の論文です
 
The isoquinoline PRL-295 increases the thermostability of Keap1 and disrupts its interaction with Nrf2 
Dayalan Naidu S, Suzuki T, Dikovskaya D, Knatko EV, Higgins M, Sato M, Novak M, Villegas JA, Moore TW, Yamamoto M, Dinkova-Kostova AT.
iScience.   25, 103703  (2022)
 
Esterification promotes the intracellular accumulation of roxadustat, an activator of hypoxia-inducible factors, to extend its effective duration 
Nakai T, Saigusa D, Iwamura Y, Matsumoto Y, Umeda K, Kato K, Yamaki H, Tomioka Y, Hirano I, Koshiba S, Yamamoto M, Suzuki N.
Biochem Pharmacol   197, 114939  (2022)
 
Target Gene Diversity of the Nrf1-MafG Transcription Factor Revealed by a Tethered Heterodimer 
Katsuoka F, Otsuki A, Hatanaka N, Okuyama H, Yamamoto M.
Mol Cell Biol.    42, e0052021  (2022)
 
Heterozygous variants in GATA2 contribute to DCML deficiency in mice by disrupting tandem protein binding 
Hasegawa A, Hayasaka Y, Morita M, Takenaka Y, Hosaka Y, Hirano I, Yamamoto M, Shimizu R.
Commun Biol.   5, 376  (2022)
 
Genomic landscape of chemical-induced lung tumors under Nrf2 different expression levels 
Satoh H, Arai Y, Furukawa E, Moriguchi T, Hama N, Urushidate T, Totoki Y, Kato M, Ohe Y, Yamamoto M, Shibata T.
Carcinogenesis   43, 613-623  (2022)
 
Halofuginone micelle nanoparticles eradicate Nrf2-activated lung adenocarcinoma without systemic toxicity 
Panda H, Suzuki M, Naito M, Saito R, Wen H, Baird L, Uruno A, Miyata K, Yamamoto M.
Free Radic Biol Med.   187, 92-104  (2022)
大学院生のPandaさんの論文です
 
The β-TrCP-Mediated Pathway Cooperates with the Keap1-Mediated Pathway in Nrf2 Degradation In Vivo 
Kuga A, Tsuchida K, Panda H, Horiuchi M, Otsuki A, Taguchi K, Katsuoka F, Suzuki M, Yamamoto M.
Mol Cell Biol.    42, e0056321  (2022)
大学院生の久我さんの論文です
 
Nrf2 protects against radiation-induced oral mucositis via antioxidation and keratin layer thickening 
Wakamori S, Taguchi K, Nakayama Y, Ohkoshi A, Sporn MB, Ogawa T, Katori Y, Yamamoto M.
Free Radic Biol Med.   188, 206-220  (2022)
大学院生の若盛さんの論文です。
 
Establishment of Neh2-Cre:tdTomato reporter mouse for monitoring the exposure history to electrophilic stress 
Kitamura H, Oishi T, Murakami S, Yamada-Kato T, Okunishi I, Yamamoto M, Katori Y, Motohashi H.
Free Radic Biol Med.    193, 610-619  (2022)

　Review
　
 
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology 
Sies H, Belousov VV, Chandel NS, Davies MJ, Jones DP, Mann GE, Murphy MP, Yamamoto M, Winterbourn C.
Nat Rev Mol Cell Biol.   23, 499-515  (2022)
 
AHR and NRF2 in Skin Homeostasis and Atopic Dermatitis 
Edamitsu T, Taguchi K, Okuyama R, Yamamoto M.
Antioxidants (Basel).   11, 227  (2022)
研究員の枝光さんの総説です
 
Multifaceted Roles of the KEAP1-NRF2 System in Cancer and Inflammatory Disease Milieu 
Panda H, Wen H, Suzuki M, Yamamoto M.
Antioxidants (Basel)   11, 538  (2022)
大学院生のPandaさんの総説です
 
The KEAP1-NRF2 System and Esophageal Cancer 
Hirose W, Oshikiri H, Taguchi K, Yamamoto M.
Cancers (Basel).   14, 4702  (2022)
 
Novel NRF2-activated cancer treatments utilizing synthetic lethality 
Baird L, Kensler TW, Yamamoto M.
IUBMB Life.   , 1209-1231  (2022)
Liam Baird助教の総説です

　日本語著書 (Publications in Japanese)
　

[編集]
CGI-design